Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

View source ↗

Summary

This study evaluates patient-reported satisfaction, effectiveness, and safety of atezolizumab when used in routine clinical practice for lung cancer and hepatoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lung Cancer, Hepatocellular Carcinoma | Status: RECRUITING